Latest Breaking News On - Epcoritamab epco - Page 1 : comparemela.com

/PRNewswire/ AbbVie (NYSE: ABBV) will present 46 abstracts across eight types of cancer during the upcoming American Society of Clinical Oncology (ASCO).

United statesRheinland pfalzLemzoparlimab lemzoEpcoritamab epcoRituximab venVenclyxto smOsimertinib osiTelisotuzumab vedotin telisoMohamed zakiTelisotuzumab vedotinNavitoclax monotherapyAbbvie companyAmerican society of clinical oncologyJanssen biotech incEuropean hematology associationUs national library of medicine